Altria has more to gain than lose in pulling e-cigarette pods, most flavors amid FDA crackdown

In appeasing the FDA, Altria has more to gain than lose. E-cigarette sales made up a fraction of Altria's $19.39 billion in revenue last fiscal year. So dropping some e-vapor products won't impact its earnings as much as companies like San Francisco startup Juul, which only sells e-cigarettes.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.